Polaryx Therapeutics Inc. Soared
Fri, Mar 13, 2026 at 07:29 PM
Polaryx Therapeutics Inc. (PLYX:NASDAQ) shot up at $6.36, representing a gain of 36.8%. On Fri, Mar 13, 2026, PLYX:NASDAQ hit a New 2-Week High of $6.36. The stock got featured on our News Catalysts scanner on Tue, Feb 17, 2026 at 11:45 AM in the 'BIOTECH' category. From Fri, Feb 27, 2026, the stock recorded 40.00% Up Days and 54.55% Green Days
The stock spiked on Tue, Mar 10, 2026 at $7.39 with a volume of 24M+.
About Polaryx Therapeutics Inc. (PLYX:NASDAQ)
Polaryx Therapeutics is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal...
Top 10 Gainers:
- Smart for Life, Inc. (SMFL:NASDAQ), 125%
- bioAffinity Technologies, Inc. (BIAF:NASDAQ), 98.13%
- Firefly Neuroscience, Inc. (AIFF:NASDAQ), 58.05%
- Silvaco Group, Inc. (SVCO:NASDAQ), 52.42%
- Elong Power Holding Limited (ELPW:NASDAQ), 43.73%
- Polaryx Therapeutics Inc. (PLYX:NASDAQ), 36.77%
- F45 Training Holdings Inc. (FXLV:NYSE), 33.33%
- iSpecimen Inc. (ISPC:NASDAQ), 26.96%
- Oruka Therapeutics, Inc. (ORKA:NASDAQ), 25.04%
- Commercial Vehicle Group, Inc. (CVGI:NASDAQ), 24.46%